• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Russian oligarch is Biopure’s new owner

Russian oligarch is Biopure’s new owner

August 24, 2009 By MassDevice

Go directly to MassDevice. Having trouble reading this email? View this newsletter in your browser here.
Not interested? Unsubscribe.

header

The MassDevice Weekly Roundup brings you the latest medical device news and information.

The MassDevice Checkup

header

 

Our weekly checkup takes the temperature of the public medical device companies in the three largest markets in the U.S.: Massachusetts, Minnesota and California. In addition to the indices for each state, which track the overall movement of the sector, we compare Monday morning’s opening share prices with their value when the markets close Friday afternoon and calculate the biggest gainers and losers. Read More more arrow

hr

News

Russian oligarch is Biopure’s new owner
A bankruptcy court approves Sergei Pugachev’s $4 million bid for the now-defunct blood substitute maker. Read More more arrow

Health Canada clears Abbott’s Xience V stent
The medical device monolith plans to immediately bring its drug-eluting stent to market north of the border. Read More more arrow

Strong 2008 drives stock gains for Thermo Fisher brass
Top executives at the Waltham, Mass.-based laboratory equipment manufacturer cash in restricted stock for a collective $470,000 profit. Read More more arrow

Study of cerebral aneurysm coiling has good news for Boston Scientific, J&J’s Cordis
The risks of re-treating brain aneurysms after endovascular coil embolization are low, according to a University of Cincinnati study. Read More more arrow

Abiomed tables Irish Impella plant
Cardiac device maker puts the brakes on the hiring drive for an Impella facility in Athlone, Ireland. Read More more arrow

HeartWare reaches clinical trial milestone
Fifty patients have been implanted with its ventricular assist system. Read More more arrow

FDA proposes new mandatory electronic filing rules
The federal watchdog wants to require manufacturers of medical devices and other products to electronically file adverse event reports. Read More more arrow

Fed court decision in Boston Scientific patent case has wide-ranging implications
A federal appeals court thwarts the Natick, Mass.-based device maker’s move to force St. Jude Medical to pony up for foreign sales of a device. Read More more arrow

Hologic touts study of fFN testing for preterm pregnancy risk
The women’s health products maker cites a British study indicating that testing pregnant women for fetal fibronectin levels can affect the way obstetricians treat their patients. Read More more arrow

Orthofix taps former Stryker exec for board
Michael Mainelli Jr. joins the board of directors of the orthopedic device maker. Read More more arrow

IntelligentMDx is ahead of schedule in developing its new Swine Flu test
The molecular diagnostics maker says it hopes to have its new influenza assay commercialized before the fast-approaching flu season. Read More more arrow

Device industry’s Q2 lobbying spend nears $8 million
Medical device industry players anted up during the second quarter, spending millions to try and influence the shape of the healthcare reform push in Washington. Read More more arrow

Studies deliver good results for Boston Scientific’s Taxus
A pair of studies bode well for the medical device leviathan’s Taxus and Taxus Express drug-eluting stents. Read More more arrow

Palomar notches its belt with another patent win
The U.S. Patent Office hands the cosmetic laser device maker another victory in its hair removal patent infringement crusade. Read More more arrow

MassDevice’s earnings roundup
A regularly updated roundup of medical device makers’ sales and earnings reports. Read More more arrow

Ronda Stryker’s selling spree continues
Total proceeds now top $52 million for the granddaughter of Stryker Corp.’s founder. Read More more arrow

Family-led fund sells one-third of Cambridge Heart stake
A father-and-son duo unloads 1.7 million shares of the Tewksbury, Mass., cardiac diagnostics firm. Read More more arrow

AdvanDx drums up $8 million
Woburn, Mass.-based molecular diagnostics maker closes Series C round. Read More more arrow

Analyst upgrades Boston Scientific
Leerink Swann analyst Rick Wise predicts good results from new CEO Ray Elliott. Read More more arrow

Orthofix lures Stryker exec away from Kalamazoo
The orthopedic device maker names a new president of its spinal implants division. Read More more arrow

Insulet taps new commercial chief
Insulin management system maker names new commercial strategy leader. Read More more arrow

hr

Blogs

Marketing Mavens: Going beyond your intellect to engage customers
These days, you have to use everything you can to make the most of precious marketing dollars. So instead of relying on your intellect alone, why not leverage your five senses? You use sound, smell, touch, taste and sight more than you realize to dimensionalize your brand. But by being more deliberate, you can take your brand even further. Read More more arrow

Compliance Corner: Fasten your seatbelts
FDA’s new focus on more stringent enforcement could mean a roller coaster ride for medical device manufacturers. Read More more arrow

Career Sampler: Open jobs in the medical device industry
An updated sampling of some of the hundreds of open positions at medical device makers around the country. Read More more arrow

Weekly Wireless Roundup: The Bluetooth stethoscope
3M unveils a new Bluetooth-enable stethoscope; reports on the efficacy of mHealth initiatives and remote patient monitoring; and new FTC rules for electronic health records. Read More more arrow

MedGadget’s MedTech Monday: Are IV bags the next fashion statement?
Check out designer Olivier Trillon’s designer-brand IV drip bags; FDA green-lights a French company’s bladder stone disintegrator; multimedia in the birthing suite; and using jet fighter technology in coronary bypass. Read More more arrow

hr

Upcoming Events

September 10-11th, Boston — Inaugural Medical Device Connectivity Conference

September 16th, Waltham, Mass. — Medical Development Group networking event: “Supernetworking: Start-up Funding in Hard Times”

NEW – October 2nd, Boston: MassMEDIC’s Annual Investors Conference

“New England is a hotbed of cutting-edge research in the medtech industry. MassMEDIC is proud to offer an opportunity for regional promising early stage companies to showcase their technologies before an audience of potential investors and strategic partners. The Investors Conference has been a seminal event for medtech start-ups, more than 250 companies have participated in the Conference since 1999 — many making their debut before investors.

“While the primary focus of the Investors Conference is on finance and investment, the annual program has also become an outstanding networking event, drawing more than 450 attendees representing every facet of medtech’s finance, manufacturing, development and service supply sectors.”

For more information visit MassMEDIC’s website.

Get listed on massdevice.com

If you would like to subscribe to this newsletter, please visit our member registration page. more arrow

© 2009 Massachusetts Medical Devices Journal LLC and its licensors. All rights reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of MMDJ.

www.MassDevice.com

Filed Under: Uncategorized Tagged With: Weekly Roundup

More recent news

  • Breaking: Sequel to launch twiist automated insulin delivery system next month
  • Dexcom shares U.S. report on CGM benefits for type 2 diabetes
  • Data backs Medtronic MiniMed 780G for type 2, children as company seeks expanded indications
  • Endogenex data supports type 2 diabetes procedure
  • Ambu wins FDA clearance for first single-use cysto-nephroscope

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy